NOV 23, 2019 11:13 PM PST

Drug Seeks To Target Treatment-Resistant Epilepsy

WRITTEN BY: Nouran Amin

Ever imagined a world where you cannot shower alone, drive by yourself, and even go to work in fear of having the next seizure that can incapacitate you? Unfortunately, this is the life of many patients with epilepsy—a chronic seizure condition. To bring hope, researchers at John Hopkins University found that an investigational drug called ‘cenobamate’ can reduce seizures by 55%.

Although there exists more than 20 anti-seizure drugs on the market, approximately half of epilepsy patients don’t become seizure-free on these medications. Cenobamate, which is not yet approved by the Food and Drug Administration (FDA), aims to target treatment-resistant epilepsy. In order for cenobamate to be approved, it must be safely administered and evaluated in 30,000 epileptic patients

“A quarter of the patients I treat with this drug [cenobamate] who were disabled by frequent partial-onset (focal) seizures now have been seizure-free for several years,” says lead investigator Gregory Krauss, M.D., professor of neurology at the Johns Hopkins University School of Medicine. “It is wonderful to see the improvement in many of my patients’ lives. They have improved confidence and can live more normal lives. Many can now work, and both patients and caretakers can be more independent.”

Learn more about epilepsy:

In the study, regular treatment was stimulated and clinical participants were given 100, 200 or 400 milligrams of cenobamate or a placebo pill with the cenobamate dose increasing for up to six weeks until the desired testing dose was reached. However, to meet FDA ethical standards, participants must remain on their regularly prescribed anti-seizure medication.

Findings of the study were published in The Lancet Neurology.

Source: Hopkins Medicine

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
JUN 10, 2020
Drug Discovery & Development
A Highly Targeted Cancer Therapeutic
JUN 10, 2020
A Highly Targeted Cancer Therapeutic
A study led by researchers at USC School of Pharmacy discusses a way to engineer drugs that highly target malignant tiss ...
JUL 04, 2020
Cardiology
Discovering a New Signal Junction Controlling Pulmonary Arterial Hypertension
JUL 04, 2020
Discovering a New Signal Junction Controlling Pulmonary Arterial Hypertension
Pulmonary Arterial Hypertension (PAH) is a progressive and fatal disease characterized by the muscularization of blood c ...
JUL 23, 2020
Cardiology
Protecting the Heart After a Heart Attack
JUL 23, 2020
Protecting the Heart After a Heart Attack
Cardiovascular disease accounts for thirty percent of mortalities around the world. These diseases start small and slowl ...
JUL 24, 2020
Cancer
A New Biomarker Candidate for Cancer Diagnostics
JUL 24, 2020
A New Biomarker Candidate for Cancer Diagnostics
One of the best tools in the fight against cancer is diagnostics. In 2018, colorectal cancer was the second most lethal ...
JUL 30, 2020
Immunology
Gene Silencing Therapy Stops the Itch of Psoriasis
JUL 30, 2020
Gene Silencing Therapy Stops the Itch of Psoriasis
A team of Harvard researchers has identified a promising new approach for treating psoriasis — a topical lotion co ...
JUL 28, 2020
Cardiology
Looking to Newborns for Help Healing Scars on the Heart
JUL 28, 2020
Looking to Newborns for Help Healing Scars on the Heart
Scars are a badge of honor to many, but they are really just a consequence of the body’s repair response. The body ...
Loading Comments...